BEGIN:VCALENDAR VERSION:2.0 PRODID:-//141.193.213.11//NONSGML kigkonsult.se iCalcreator 2.20// CALSCALE:GREGORIAN METHOD:PUBLISH X-FROM-URL:https://catalyst-hm.com X-WR-TIMEZONE:America/New_York BEGIN:VTIMEZONE TZID:America/New_York X-LIC-LOCATION:America/New_York BEGIN:STANDARD DTSTART:20231105T020000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST END:STANDARD BEGIN:DAYLIGHT DTSTART:20240310T020000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:ai1ec-205591@catalyst-hm.com DTSTAMP:20240329T115518Z CATEGORIES;LANGUAGE=en-US:Grand Rounds\,New York CONTACT: DESCRIPTION:
Tuesday\, September 7\, 2021
\n12:00-1:00pm
Location
\nBrooklyn\, NY
Sp
eaker
\nDavid Rizzieri\, MD
Tuesday\, September 7\, 2021
\n2:00-3:00pm<
/p>\n
Location
\nHouston\, TX
Spea
ker
\nDavid Rizzieri\, MD
Thursday\, September 9\, 2021
\n12:00-1:00p
m
Location
\nChicago\, IL
Sp
eaker
\nAlice S. Mims\, MD\, MSCR
Thursday\, September 9\, 2021
\n4:30-5:30pm
Location
\nBaltimore\, MD
S
peaker
\nAlice S. Mims\, MD\, MSCR
Friday\, September 10\, 2021
\n12:00-1:00pm
Location
\nCanton\, OH
Spea
ker
\nDavid Rizzieri\, MD
Tuesday\, September 14\, 2021
\n12:00-1:00p
m
Location
\nHudson\, NY
Spe
aker
\nDavid Rizzieri\, MD
Thursday\, September 23\, 2021
\n10:00-11:0
0am
Location
\nStaten Island\, NY
Speaker
\nJeffrey E. Lancet\, MD
Thursday\, September 23\, 2021
\n12:00-1:00
pm
Location
\nTemple\, TX
Sp
eaker
\nAlice S. Mims\, MD\, MSCR
Friday\, September 24\, 2021
\n12:15-1:15pm
Location
\nDecatur\, GA
Spe
aker
\nJoshua Zeidner\, MD
Monday\, September 27\, 2021
\n12:00-1:00pm
Location
\nBrooklyn\, NY
Sp
eaker
\nDavid Rizzieri\, MD
Monday\, September 27\, 2021
\n7:30-8:30am<
/p>\n
Location
\nWhite Plains\, NY
Speaker
\nHetty Carraway\, MD\, MBA
Saturday\, October 2\, 2021
\n12:00-1:00pm<
/p>\n
Location
\nLubbock\, TX
Spea
ker
\nTapan M. Kadia\, MD
Date: Wednesday\, Octob
er 6\, 2021
\nTime: 7:00 PM – 9:00 PM EST
To pre-register for the live event\, please visit www.MLG-HM.com or call 1 -207-847-0613
\n\nThursday\, October 7\, 2021
\n12:00-1:00pm<
/p>\n
Location
\nChicago\, IL
Spea
ker
\nHetty Carraway\, MD\, MBA
Thursday\, October 14\, 2021
\n12:00-1:00pm
Location
\nN/A
Speaker
\nAlice S. Mims\, MD\, MSCR
Wednesday\, October 20\, 2021
\n12:15-1:15p
m
Location
\nOxnard\, CA
Sp
eaker
\nDavid Rizzieri\, MD
Thursday\, October 21\, 2021
\n7:30-8:30am<
/p>\n
Location
\nPhiladelphia\, PA
Speaker
\nTapan M. Kadia\, MD
Friday\, October 22\, 2021
\n8:00-9:00am
Location
\nBrooklyn\, NY
Speak
er
\nAnjali Advani\, MD
Wednesday\, October 27\, 2021
\n12:00-1:00p
m
Location
\nHoboken\, NJ
Sp
eaker
\nJoshua Zeidner\, MD
Thursday\, October 28\, 2021
\n12:00-1:00pm
Location
\nN/A
Speaker
\nAlice S. Mims\, MD\, MSCR
Wednesday\, November 3\, 2021
\n7:30-8:30am
Location
\nRichmond\, IN
Sp
eaker
\nJoshua Zeidner\, MD
Friday\, November 5\, 2021
\n8:00-9:00am
Location
\nSalisbury\, MD
Spea
ker
\nJoshua Zeidner\, MD
Tuesday\, November 9\, 2021
\n12:00-1:00pm<
/p>\n
Location
\nBrooklyn\, NY
Spe
aker
\nTapan M. Kadia\, MD
Thursday\, November 11\, 2021
\n9:00-10:00a
m
Location
\nFort Lauderdale\, FL
Speaker
\nDavid Rizzieri\, MD
Thursday\, November 11\, 2021
\n12:00-1:00p
m
Location
\nN/A
Speaker
\nTapan M. Kadia\, MD
Thursday\, November 11\, 2021
\n1:00-2:00pm
Location
\nOrlando\, FL
Spe
aker
\nDavid Rizzieri\, MD
Wednesday\, November 17\, 2021
\n1:15-2:15p
m
Location
\nBrooklyn\, NY
S
peaker
\nJeffrey E. Lancet\, MD
Friday\, November 19\, 2021
\n12:00-1:00pm<
/p>\n
Location
\nGoodyear\, AZ
Spe
aker
\nDavid Rizzieri\, MD
Monday\, November 22\, 2021
\n12:00-1:00pm<
/p>\n
Location
\nBuffalo\, NY
Spea
ker
\nAnjali Advani\, MD
Tuesday\, November 30\, 2021
\n8:00-9:00am<
/p>\n
Location
\nGoshen\, IN
Speak
er
\nJoshua Zeidner\, MD
Wednesday\, December 1\, 2021
\n2:00-3:00pm
Location
\nNashville\, TN
S
peaker
\nAlice S. Mims\, MD\, MSCR
Location
\nGeorgia World Congress Center\n285 Andrew Young Int’l Blvd. NW
\nAtlanta\, GA 30313
Bo oth 2471
\nVISIT OUR VIRTUAL REALITY ROOM – EXHIBIT HALL HOU RS
\nSaturday\, December 11\, 2021 ~ 11:00 AM – 5:00 PM
\nSunday\, December 12\, 2021 ~ 10:00 AM – 5:00 PM
\nMonday\, Decem
ber 13\, 2021 ~ 10:00 AM – 2:00 PM
REG ISTER FOR LIVE CME PROGRAM
\nWednesday\, October 19\, 2022
\n6:00 PM – 8:00 PM EDT
\nVirtual Symposium live at: 6:00 PM Easter n\; 5:00 PM Central\; 4:00 PM Mountain\; 3:00 PM Pacific
\nFACULTY
\n\n | Michael R. Grunwald\, MD \nChief\, Leukemia Divisio n \nDirector\, Transplantation and Cellular Therapy Program \nLe vine Cancer Institute\, Atrium Health \nCharlotte\, NC | \n\n | Ryan
Jacobs\, MD \nPrinciple Investigator of CLL Clinical Trials \nDepartment of Hematology\, Lymphoma Division \nAssistant Prof essor of Medicine \nLevine Cancer Institute\, Atrium Health \nCh arlotte\, NC | \n\n\n
LEARNING OBJECTIV ES
\nUpon the completion of this program\, attendees should be able to:
\nTARGET AUDIENCE
\nTh is virtually live activity is intended for US-based hematologists\, medica l oncologists\, and other healthcare providers involved in the management of patients with CLL and/or AML.
\nACCREDITATION STATEMENT strong>
\nMed Learning Group is accredited by the Accreditation Coun cil for Continuing Medical Education to provide continuing medical educati on for physicians. This CME activity was planned and produced in accordanc e with the ACCME Essentials.
\nCREDIT DESIGNATION STATEMENT< /strong>
\nMed Learning Group designates this virtually live activit y for a maximum of 2.0 AMA PRA Category 1 CreditsTM< /sup>. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
\nNURSING CREDIT INFORMATION
\nPurpose: This program
would be beneficial for nurses involved in the care of patients with CLL a
nd/or AML.
\nCNE Credits: 2.0 ANCC Contact
Hours
CNE ACCREDITATION STATEMENT
\n< p>Ultimate Medical Academy/Complete Conference Management (CCM) is accredi ted as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation .\nAwarded 2.0 contact hour(s) of continuing nursing education of R Ns and APNs.
\nDISCLAIMER
\nMed Learning Grou p makes every effort to develop CME activities that are scientifically bas ed. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn b y the participants should be derived from careful consideration of all ava ilable scientific information. The participant should use his/her clinical judgment\, knowledge\, experience\, and diagnostic decision-making before applying any information\, whether provided here or by others\, for any p rofessional use.
\nFor CME questions\, please contact Med Learning G roup at info@me dlearninggroup.com
\nContact this CME provider at Med Learning G roup for privacy and confidentiality policy statement information at www. medlearninggroup.com/privacy-policy/
\nAMERICANS WITH DI SABILITY ACT
\nStaff will be glad to assist you with any sp ecial needs. Please contact Med Learning Group prior to participating at < a href='mailto:info@medlearninggroup.com' target='_blank'>info@medlearning group.com
\n\nREGISTER FOR LIVE CME PROGRAM< /p>\n\n
REGISTER FOR LIVE VIRTUAL PROGRAM
\nFriday\, July 14\, 2023
\n12:00PM – 1:00PM ET
\nPlease note this virtual program is 12:00 PM Eastern\, 11:00AM Central\, 10:00AM Mountain and 9:00AM Pacific.
\n< p> FACULTY\n\n | <
strong>Courtney D. DiNardo\, MD\, MSCE \nAssociate Professor \, Department of Leukemia \nDivision of Cancer Medicine \nThe Un iversity of Texas MD Anderson Cancer Center | \n
PROGRAM OVERVIEW
\nIn this program\, we will discuss how healthcare providers within the Department of Veterans Affairs can improve their treatment of patients with Acute Myeloid Leukemia (AML) by providing updates on key biological features and biomarkers of AML to inform patient assessment with novel therapies. In addition\, we will revi ew the latest data in the management of AML and challenges in effectively communicating rationale for therapeutic decisions with patients and caregi vers.
\nTARGET AUDIENCE
\nThis educational ac tivity is intended for US-based hematologists\, medical oncologists\, and other healthcare providers involved in the management of patients with AML within the Department of Veterans Affairs.
\nEDUCATIONAL OB JECTIVES
\nUpon the completion of this program\, attendees should be able to:
\nACCREDITATION STATEMENT
\nMed L
earning Group is accredited by the Accreditation Council for Continuing Me
dical Education (ACCME) to provide continuing medical education for physic
ians.
This CME activity was planned and produced in accordance wit h the ACCME Essentials.
\nPHYSICIAN CREDIT DESIGNATION STATE
MENT
\nMed Learning Group designates this live activity for
a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only
the credit commensurate with the extent of their participation in the live
activity.
JOINT ACCREDITATION STATEMENT
\nIn support of improving patient care \, this activity has been planned and implemented by Amedco LLC and Med Le arning Group. Amedco LLC is jointly accredited by the Accreditation Counci l for Continuing Medical Education (ACCME)\, the Accreditation Council for Pharmacy Education (ACPE)\, and the American Nurses Credentialing Center (ANCC)\, to provide continuing education for the healthcare team.
\nNURSES (ANCC) CREDIT DESIGNATION
\nAmedco LLC desig nates this virtually live activity for a maximum of 1.0 ANCC contact hour.
\nDISCLOSURE POLICY STATEMENT
\nIn accordanc e with the Accreditation Council for Continuing Medical Education ACCME St andards for Integrity and Independence in Accredited Continuing Education\ , educational programs sponsored by Med Learning Group must demonstrate ba lance\, independence\, objectivity\, and scientific rigor. All faculty\, a uthors\, editors\, staff\, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed i n an educational activity.
\nDISCLOSURE OF UNLABELED USE
\nMed Learning Group requires that faculty participating in an y CME activity disclose to the audience when discussing any unlabeled or i nvestigational use of any commercial product or device not yet approved fo r use in the United States. During the course of this lecture\, the facult y may mention the use of medications for both FDA-approved and non-approve d indications.
\nDISCLAIMER
\nMed Learning Gr oup makes every effort to develop CME activities that are scientifically b ased. This activity is designed for educational purposes. Participants hav e a responsibility to utilize this information to enhance their profession al development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all a vailable scientific information. The participant should use his/her clinic al judgment\, knowledge\, experience\, and diagnostic decision-making expe rtise before applying any information\, whether provided here or by others \, for any professional use.
\nFor CME questions\, please contact Me d Learning Group at info@medlearninggroup.com
\nContact this CME provider at Me d Learning Group for privacy and confidentiality policy statement informat ion at www.medlearninggroup.com/privacy-policy/
\nAMERI CANS WITH DISABILITIES ACT
\nEvent staff will be glad to as sist you with any special needs. Please contact Med Learning Group at info@medlearninggro up.com
\n\n\n\nREGISTER FOR LIVE VIRTUAL PROGRAM
\nThursday\, August 10\, 2023
\n12:00PM – 1:00PM ET
\nPleas e note this virtual program is 12:00PM Eastern\, 11:00AM Central\, 10:00AM Mountain and 9:00AM Pacific
\nFACULTY
\n\n | Lori Leslie
\, MD \nAssociate Professor of Medicine \nHackensack Meridian He alth School of Medicine \nDirector of CLL and Indolent Lymphoma \nJohn Theurer Cancer Center \nHackensack\, NJ | \n
PROGRAM OVERVIEW
\nIn this activity we will discuss the relevance of specific genetic and molecular markers in Chronic Lymphocytic Leukemia (CLL)\, review the current evidence concerni ng the application of minimal residual disease (MRD) monitoring\, and emer ging strategies and combinations for CLL management in first-line and rela psed/refractory settings. Finally\, we will examine the potential adverse events associated with CLL therapeutics\, including specific consideration s with combination therapies.
\nTARGET AUDIENCE
\nThis educational activity is intended for community hematologists\, o ncologists\, and clinicians involved in the assessment\, monitoring\, and treatment of CLL for patients within the Department of Veteran Affairs.
\nLEARNING OBJECTIVES
\nUpon the completion of this program\, attendees should be able to:
\nACCREDITATION STATEMEN
T
\nMed Learning Group is accredited by the Accreditation Co
uncil for Continuing Medical Education (ACCME) to provide continuing medic
al education for physicians.
This CME activity was planned and pro duced in accordance with the ACCME Essentials.
\nPHYSICIAN C
REDIT DESIGNATION STATEMENT
\nMed Learning Group designates
this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physic
ians should claim only the credit commensurate with the extent of their pa
rticipation in the live activity.
JOINT ACCREDITATION STAT EMENT
\nIn support of improving patient care\, this activity has been planned and implemented b y Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by t he Accreditation Council for Continuing Medical Education (ACCME)\, the Ac creditation Council for Pharmacy Education (ACPE)\, and the American Nurse s Credentialing Center (ANCC)\, to provide continuing education for the he althcare team.
\nNURSES (ANCC) CREDIT DESIGNATION p>\n
Amedco LLC designates this virtually live activity for a maximum of 1.0 ANCC contact hour.
\nDISCLOSURE POLICY STATEMENT
\nIn accordance with the Accreditation Council for Continuing Med ical Education ACCME Standards for Integrity and Independence in Accredite d Continuing Education\, educational programs sponsored by Med Learning Gr oup must demonstrate balance\, independence\, objectivity\, and scientific rigor. All faculty\, authors\, editors\, staff\, and planning committee m embers participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufactur er(s) of any commercial product(s) and/or provider(s) of commercial servic es that are discussed in an educational activity.
\nDISCLOSU RE OF UNLABELED USE
\nMed Learning Group requires that facu lty participating in any CME activity disclose to the audience when discus sing any unlabeled or investigational use of any commercial product or dev ice not yet approved for use in the United States. During the course of th is lecture\, the faculty may mention the use of medications for both FDA-a pproved and non-approved indications.
\nDISCLAIMER< /p>\n
Med Learning Group makes every effort to develop CME activities th at are scientifically based. This activity is designed for educational pur poses. Participants have a responsibility to utilize this information to e nhance their professional development in an effort to improve patient outc omes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant sh ould use his/her clinical judgment\, knowledge\, experience\, and diagnost ic decision-making expertise before applying any information\, whether pro vided here or by others\, for any professional use.
\nFor CME questi ons\, please contact Med Learning Group at info@medlearninggroup.com
\nContact this CME provider at Med Learning Group for privacy and confidentiality po licy statement information at www.medlearninggroup.com/privacy-policy/
\nAMERICANS WITH DISABILITIES ACT
\nEvent s taff will be glad to assist you with any special needs. Please contact Med Learning Group at info@medlearninggroup.com
\n\n\n\nVisit our Virtual Reality Room at Booth 755!
\nExhibit Hall Hours:
\nDecember 9: 11:00 am – 5:
00 pm
\nDecember 10: 10:00 am – 5:00 pm
\nDecember 11: 10:00 am
– 2:00 pm